Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an open-label, randomised, phase 3 trial
Earl, Helena M, Professor, Hiller, Louise, PhD, Howard, Helen C, PhD, Dunn, Janet A, Prof, Young, Jennie, BA, Bowden, Sarah J, PhD, McDermaid, Michelle, Waterhouse, Anna K, BSc, Wilson, Gregory, FRCP, Agrawal, Rajiv, FRCR, O'Reilly, Susan, MD, Bowman, Angela, MB ChB, Ritchie, Diana M, MD, Goodman, Andrew, MB ChB, Hickish, Tamas, Prof, McAdam, Karen, FRCP, Cameron, David, Prof, Dodwell, David, Prof, Rea, Daniel W, FRCP, Caldas, Carlos, Prof, Provenzano, Elena, PhD, Abraham, Jean E, PhD, Canney, Peter, MD, Crown, John P, Prof, Kennedy, M John, Prof, Coleman, Robert, Prof, Leonard, Robert C, Prof, Carmichael, James A, MD, Wardley, Andrew M, Prof, Poole, Christopher J, Prof
Published in The lancet oncology (01.06.2017)
Published in The lancet oncology (01.06.2017)
Get full text
Journal Article